|
|||||
|
|
Can SGLT2 Inhibitor be Used for Diabetes Mellitus or Vascular Diseases? |
|
| Authors: | Takashi Nomiyama |
| Affiliation: | Department of Diabetes, Metabolism and Endocrinology, International University of Health and Welfare Ichikawa Hospital, Chiba, Japan |
| Abstract: | |
| Keywords: | |
